• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human Asymmetric DiMethyl-Histone H3-R17 Polyclonal Antibody

The antibody against Asymmetric DiMethyl-Histone H3-R17 was raised in Rabbit using a synthetic peptide corresponding to a sequence within amino acids 1-100 of human histone H3 (NP_003520.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

ADA-12600A

The antibody against Asymmetric DiMethyl-Histone H3-R17 was raised in Rabbit using a synthetic peptide corresponding to a sequence within amino acids 1-100 of human histone H3 (NP_003520.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-12600A ClonalityPolyclonal
Host SpeciesRabbitTarget NameAsymmetric DiMethyl-Histone H3-R17
Target SynonymsH3/j; H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3FJ; H3C10; H3C11; HIST1H3J; Asymmetric DiMethyl-Histone H3-R17FormLiquid
Species ReactivityHuman, Mouse, Rat, Other (Wide Range Predicted)IsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.05% proclin300, pH7.3.Purification MethodAffinity purification
Positive SamplesC6, HeLa, NIH/3T3ApplicationELISA, WB, IF/ICC

Immunogen Information


Immunogen DescriptionA synthetic peptide corresponding to a sequence within amino acids 1-100 of human Histone H3 (NP_003520.1).Target SpeciesHuman
Immunogen SequenceMARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEACEAYUniprot IDQ16695, P68431

Inquire Rabbit anti-Human Asymmetric DiMethyl-Histone H3-R17 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification